dantrolene use for the treatment of neuroleptic malignant syndrome (NMS)

PLEASE NOTE:   Posts made to this forum should not be considered as the expressed opinions of, nor should be considered endorsed by, the Medication Safety Officer’s Society (MSOS) or the Institute for Safe Medication Practices (ISMP). 

Make sure your email is up-to-date
In order to continue to receive updates from MSOS, as well as forum posts and other valuable information as a member of MSOS, please be sure to update your email address with us, whenever it changes. If you need assistance doing so, please send an email to jgold@ismp.org

1 post / 0 new
H. Kwame Adjei
H. Kwame Adjei's picture
Offline
Last seen: 2 weeks 1 day ago
Joined: 09/24/2015 - 13:59
dantrolene use for the treatment of neuroleptic malignant syndrome (NMS)

Quick question folks:

I wanted to know if dantrolene use in the setting of NMS (OR dantrolene use in general) at your facility always require the patient to be in the ICU.

Thank you.